SAKAR HEALTHCARE
|
SAKAR HEALTHCARE Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Profit Before Tax | ₹17 Cr | ₹19 Cr | ₹13 Cr | ₹12 Cr |
Adjustment | ₹20 Cr | ₹12 Cr | ₹8.90 Cr | ₹9.19 Cr |
Changes In working Capital | ₹0.60 Cr | ₹4.09 Cr | ₹-6.83 Cr | ₹0.22 Cr |
Cash Flow after changes in Working Capital | ₹38 Cr | ₹36 Cr | ₹15 Cr | ₹22 Cr |
Cash Flow from Operating Activities | ₹33 Cr | ₹36 Cr | ₹15 Cr | ₹19 Cr |
Cash Flow from Investing Activities | ₹-74 Cr | ₹-90 Cr | ₹-47 Cr | ₹-22 Cr |
Cash Flow from Financing Activities | ₹41 Cr | ₹55 Cr | ₹32 Cr | ₹3.48 Cr |
Net Cash Inflow / Outflow | ₹0.06 Cr | ₹-0.05 Cr | ₹-0.22 Cr | ₹-0.06 Cr |
Opening Cash & Cash Equivalents | ₹0.03 Cr | ₹0.08 Cr | ₹0.31 Cr | ₹0.37 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - |
Closing Cash & Cash Equivalent | ₹0.09 Cr | ₹0.03 Cr | ₹0.08 Cr | ₹0.31 Cr |
Compare Cashflow Statement of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹799.2 Cr | 4% | -5.4% | 64.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹388,812.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹120,673.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,679.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,152.0 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹91,234.9 Cr | -1.6% | -7% | 23.8% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | 4% |
-5.4% |
64.5% |
SENSEX | -0.4% |
-0.9% |
25.8% |
You may also like the below Video Courses